{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:19:14Z","timestamp":1787761154427,"version":"build-2784847793"},"reference-count":27,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.modpat.2026.101019","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T23:14:32Z","timestamp":1779750872000},"page":"101019","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gynecologic Tumors and Precursor Lesions, Including p53-Aberrant Atypical Hyperplasia\u2013like Endometrial Lesions, in Li-Fraumeni Syndrome"],"prefix":"10.1016","volume":"39","author":[{"given":"Yurika","family":"Nishikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozge","family":"Ceyhan-Birsoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier","family":"Selenica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Mandelkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7220-3996","authenticated-orcid":false,"given":"M. Herman","family":"Chui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.modpat.2026.101019_bib1","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1001\/jamaoncol.2021.4398","article-title":"Analysis of the Li-Fraumeni spectrum based on an international germline TP53 variant data set: an International Agency for Research on Cancer TP53 database analysis","volume":"7","author":"Kratz","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.modpat.2026.101019_bib2","article-title":"Cancer risks associated with TP53 pathogenic variants: maximum likelihood analysis of extended pedigrees for diagnosis of first cancers beyond the Li-Fraumeni syndrome spectrum","volume":"8","author":"Fortuno","year":"2024","journal-title":"JCO Precis Oncol"},{"issue":"12","key":"10.1016\/j.modpat.2026.101019_bib3","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1093\/jnci\/djab117","article-title":"Paired tumor-normal sequencing provides insights into the TP53-related cancer spectrum in patients with Li-Fraumeni syndrome","volume":"113","author":"Ceyhan-Birsoy","year":"2021","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.modpat.2026.101019_bib4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10689-017-0002-1","article-title":"Next generation sequencing is informing phenotype: a TP53 example","volume":"17","author":"O'Shea","year":"2018","journal-title":"Fam Cancer"},{"issue":"2","key":"10.1016\/j.modpat.2026.101019_bib5","first-page":"83","article-title":"Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers","volume":"10","author":"Nichols","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"10.1016\/j.modpat.2026.101019_bib6","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/cncr.27720","article-title":"BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma","volume":"119","author":"Pennington","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.modpat.2026.101019_bib7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1471-2350-14-129","article-title":"Multiplex genetic cancer testing identifies pathogenic mutations in TP53 and CDH1 in a patient with bilateral breast and endometrial adenocarcinoma","volume":"14","author":"Heitzer","year":"2013","journal-title":"BMC Med Genet"},{"issue":"3","key":"10.1016\/j.modpat.2026.101019_bib8","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/PGP.0000000000000792","article-title":"Endometrial carcinoma as the presenting malignancy in a teenager with a pathogenic TP53 germline mutation: a case report and literature review","volume":"41","author":"Irshaid","year":"2022","journal-title":"Int J Gynecol Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101019_bib9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/path.2624","article-title":"The Li-Fraumeni syndrome (LFS): a model for the initiation of p53 signatures in the distal fallopian tube","volume":"220","author":"Xian","year":"2010","journal-title":"J Pathol"},{"issue":"3","key":"10.1016\/j.modpat.2026.101019_bib10","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/PAS.0000000000001810","article-title":"Reliable identification of endometrial precancers through combined Pax2, \u03b2-catenin, and Pten immunohistochemistry","volume":"46","author":"Aguilar","year":"2022","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.modpat.2026.101019_bib11","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","article-title":"Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology","volume":"17","author":"Cheng","year":"2015","journal-title":"J Mol Diagn"},{"issue":"6453","key":"10.1016\/j.modpat.2026.101019_bib12","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1126\/science.aax3649","article-title":"A dominant-negative effect drives selection of TP53 missense mutations in myeloid malignancies","volume":"365","author":"Boettcher","year":"2019","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.modpat.2026.101019_bib13","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ygyno.2021.02.015","article-title":"Genetic and molecular subtype heterogeneity in newly diagnosed early- and advanced-stage endometrial cancer","volume":"161","author":"Da Cruz Paula","year":"2021","journal-title":"Gynecol Oncol"},{"issue":"7","key":"10.1016\/j.modpat.2026.101019_bib14","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1097\/PAS.0b013e31802d68ce","article-title":"Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins","volume":"31","author":"Wheeler","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101019_bib15","doi-asserted-by":"crossref","first-page":"4995","DOI":"10.1038\/s41467-020-18819-5","article-title":"Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome","volume":"11","author":"Hollis","year":"2020","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.modpat.2026.101019_bib16","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/his.14593","article-title":"Well-differentiated lipomatous neoplasms with p53 alterations: a clinicopathological and molecular study of eight cases with features of atypical pleomorphic lipomatous tumour","volume":"80","author":"Hammer","year":"2022","journal-title":"Histopathology"},{"issue":"9","key":"10.1016\/j.modpat.2026.101019_bib17","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.21873\/anticanres.17227","article-title":"Real-world comparison of p53 immunohistochemistry and TP53 mutation analysis using next-generation sequencing","volume":"44","author":"Lee","year":"2024","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.modpat.2026.101019_bib18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10549-024-07357-z","article-title":"p53 protein expression patterns associated with TP53 mutations in breast carcinoma","volume":"207","author":"Anderson","year":"2024","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.modpat.2026.101019_bib19","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1158\/0008-5472.CAN-25-3189","article-title":"Integrated spatial analysis reveals the molecular landscape of ovarian precancerous lesions","volume":"86","author":"Chang","year":"2026","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.modpat.2026.101019_bib20","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nrm4025","article-title":"Short- and long-term effects of chromosome mis-segregation and aneuploidy","volume":"16","author":"Santaguida","year":"2015","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"10.1016\/j.modpat.2026.101019_bib21","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1159\/000489261","article-title":"What should a gynecologist know about Li-Fraumeni syndrome? Lessons from a patient undergoing hysterectomy for benign indications","volume":"83","author":"Advolodkina","year":"2018","journal-title":"Gynecol Obstet Invest"},{"issue":"7447","key":"10.1016\/j.modpat.2026.101019_bib22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.modpat.2026.101019_bib23","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/PAS.0000000000002401","article-title":"Clinicopathologic and genomic analysis of uterine serous carcinomas arising from endometrial hyperplasia","volume":"49","author":"Sia","year":"2025","journal-title":"Am J Surg Pathol"},{"issue":"23","key":"10.1016\/j.modpat.2026.101019_bib24","doi-asserted-by":"crossref","first-page":"4949","DOI":"10.1158\/1078-0432.CCR-23-1397","article-title":"Clinical behavior and molecular landscape of stage I p53-abnormal low-grade endometrioid endometrial carcinomas","volume":"29","author":"Jamieson","year":"2023","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.modpat.2026.101019_bib25","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/PGP.0000000000001113","article-title":"Molecular subtype and mutational profile of endometrial atypical hyperplasia\/endometrioid intraepithelial neoplasia","volume":"45","author":"Leino","year":"2026","journal-title":"Int J Gynecol Pathol"},{"issue":"21","key":"10.1016\/j.modpat.2026.101019_bib26","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1002\/cncr.33143","article-title":"What 20 years of research has taught us about the TP53 p.R337H mutation","volume":"126","author":"Pinto","year":"2020","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.modpat.2026.101019_bib27","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1086\/302575","article-title":"Are there low-penetrance TP53 alleles? Evidence from childhood adrenocortical tumors","volume":"65","author":"Varley","year":"1999","journal-title":"Am J Hum Genet"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395226000621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395226000621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:25:03Z","timestamp":1787757903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395226000621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0893395226000621"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2026.101019","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gynecologic Tumors and Precursor Lesions, Including p53-Aberrant Atypical Hyperplasia\u2013like Endometrial Lesions, in Li-Fraumeni Syndrome","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2026.101019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 United States & Canadian Academy of Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101019"}}